Bruker Pre-Tax Profit Margin 2010-2024 | BRKR
Current and historical pre-tax profit margin for Bruker (BRKR) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bruker pre-tax profit margin for the three months ending March 31, 2024 was .
| Bruker Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-03-31 |
$3.00B |
$0.51B |
16.99% |
| 2023-12-31 |
$2.96B |
$0.55B |
18.39% |
| 2023-09-30 |
$2.82B |
$0.43B |
15.08% |
| 2023-06-30 |
$2.71B |
$0.44B |
16.03% |
| 2023-03-31 |
$2.62B |
$0.43B |
16.30% |
| 2022-12-31 |
$2.53B |
$0.41B |
16.36% |
| 2022-09-30 |
$2.51B |
$0.41B |
16.49% |
| 2022-06-30 |
$2.48B |
$0.39B |
15.88% |
| 2022-03-31 |
$2.46B |
$0.40B |
16.40% |
| 2021-12-31 |
$2.42B |
$0.39B |
16.29% |
| 2021-09-30 |
$2.36B |
$0.38B |
16.08% |
| 2021-06-30 |
$2.27B |
$0.35B |
15.28% |
| 2021-03-31 |
$2.12B |
$0.30B |
14.02% |
| 2020-12-31 |
$1.99B |
$0.23B |
11.37% |
| 2020-09-30 |
$1.96B |
$0.23B |
11.79% |
| 2020-06-30 |
$1.97B |
$0.24B |
12.13% |
| 2020-03-31 |
$2.04B |
$0.26B |
12.58% |
| 2019-12-31 |
$2.07B |
$0.28B |
13.51% |
| 2019-09-30 |
$2.03B |
$0.27B |
13.28% |
| 2019-06-30 |
$1.97B |
$0.25B |
12.73% |
| 2019-03-31 |
$1.93B |
$0.25B |
12.77% |
| 2018-12-31 |
$1.90B |
$0.24B |
12.86% |
| 2018-09-30 |
$1.87B |
$0.23B |
12.43% |
| 2018-06-30 |
$1.84B |
$0.22B |
11.67% |
| 2018-03-31 |
$1.81B |
$0.20B |
11.14% |
| 2017-12-31 |
$1.77B |
$0.20B |
11.21% |
| 2017-09-30 |
$1.71B |
$0.20B |
11.55% |
| 2017-06-30 |
$1.66B |
$0.19B |
11.60% |
| 2017-03-31 |
$1.62B |
$0.18B |
11.17% |
| 2016-12-31 |
$1.61B |
$0.18B |
10.99% |
| 2016-09-30 |
$1.62B |
$0.16B |
9.64% |
| 2016-06-30 |
$1.62B |
$0.14B |
8.45% |
| 2016-03-31 |
$1.65B |
$0.14B |
8.75% |
| 2015-12-31 |
$1.62B |
$0.13B |
7.88% |
| 2015-09-30 |
$1.65B |
$0.11B |
6.35% |
| 2015-06-30 |
$1.68B |
$0.09B |
5.36% |
| 2015-03-31 |
$1.74B |
$0.10B |
5.64% |
| 2014-12-31 |
$1.81B |
$0.10B |
5.64% |
| 2014-09-30 |
$1.85B |
$0.11B |
6.04% |
| 2014-06-30 |
$1.87B |
$0.13B |
6.94% |
| 2014-03-31 |
$1.87B |
$0.13B |
7.11% |
| 2013-12-31 |
$1.84B |
$0.13B |
6.80% |
| 2013-09-30 |
$1.80B |
$0.11B |
5.88% |
| 2013-06-30 |
$1.81B |
$0.14B |
7.56% |
| 2013-03-31 |
$1.78B |
$0.12B |
6.75% |
| 2012-12-31 |
$1.79B |
$0.14B |
7.76% |
| 2012-09-30 |
$1.75B |
$0.16B |
8.91% |
| 2012-06-30 |
$1.72B |
$0.14B |
7.97% |
| 2012-03-31 |
$1.70B |
$0.15B |
8.88% |
| 2011-12-31 |
$1.65B |
$0.15B |
8.78% |
| 2011-09-30 |
$1.59B |
$0.15B |
9.11% |
| 2011-06-30 |
$1.48B |
$0.14B |
9.70% |
| 2011-03-31 |
$1.38B |
$0.15B |
10.48% |
| 2010-12-31 |
$1.31B |
$0.15B |
11.57% |
| 2010-09-30 |
$1.26B |
$0.17B |
13.71% |
| 2010-06-30 |
$1.21B |
$0.16B |
13.06% |
| 2010-03-31 |
$1.16B |
$0.14B |
12.13% |
| 2009-12-31 |
$1.12B |
$0.13B |
11.48% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$10.187B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
